• Nasdaq staff moved to delist Jupiter Neurosciences’ common stock from the Nasdaq Capital Market on Aug. 27, 2026.
• Market value of listed securities stayed below the $35 million minimum under Nasdaq Listing Rule 5550(b)(2) through Aug. 25, 2026.
• An appeal to the Nasdaq Hearings Panel is planned, which is expected to stay the delisting pending a final decision.
• Separately, the stock regained compliance with Nasdaq’s $1 minimum bid price rule after 10 straight sessions at or above $1.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-040577), on August 28, 2026, and is solely responsible for the information contained therein.